Naratriptan

From Wikipedia, the free encyclopedia

Naratriptan
Systematic (IUPAC) name
N-methyl-2-[3-(1-methyl-4-piperidyl
)-1H-indol-5-yl]-ethanesulfonamide
Identifiers
CAS number 121679-13-8
ATC code N02CC02
PubChem 4440
DrugBank APRD00220
Chemical data
Formula C17H25N3O2S 
Mol. mass 335.465 g/mol
Pharmacokinetic data
Bioavailability 74%
Metabolism Hepatic
Half life 5-8 hours
Excretion Renal
Therapeutic considerations
Pregnancy cat.

B3(AU) C(US)

Legal status

Prescription only

Routes Oral

Naratriptan (trade name Amerge) is a triptan drug developed by Glaxo Wellcome Inc. and is used for the treatment of migraine headaches. Naratriptan is available in 2.5 mg tablets. It is a selective 5-hydroxytryptamine1 receptor subtype agonist. Naratriptan hydrochloride is chemically designated as N-methyl-3-( 1-methyl-4-piperidinyl)-1H-indole-5-ethanesulfonamide.

Some side effects of the drug include vision changes, tingling sensations, tiredness or weakness, upset stomach, dizziness, and warm/cold temperature sensations. The U.S. Food and Drug Administration (FDA) approved naratriptan on February 11, 1998.

[edit] Side effects

Side effects include: dizziness, drowsiness, tingling of the hands or feet, unusual tiredness, nausea, dry mouth and unsteadiness. If these effects persist or worsen, notify your doctor promptly. Side-effects which are unlikely and which should be promptly reported include: chest pain/pressure, throat pain/pressure, unusually fast/slow/irregular pulse, one-sided muscle weakness, vision problems, cold/bluish hands or feet, stomach pain, bloody diarrhea, mental/mood changes, and fainting. In the unlikely event you have a serious allergic reaction to this drug, seek immediate medical attention. Symptoms of a serious allergic reaction include: rash, itching, swelling, severe dizziness, trouble breathing.


Languages